Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nordic Capital
DescriptionAssay that measures kappa and lambda immunoglobulin-free light chains
Molecular Target Immunoglobulin light chain (IgLC)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose and manage multiple myeloma (MM); Predict non-Hodgkin's lymphoma (NHL) in patients with HIV
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today